Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lung Cancer Immunotherapy With Vaccine 1650-G and Yeast Derived β-Glucan

NCT01829373 is registered in ClinicalTrials.gov with Edward Hirschowitz as lead sponsor.

NCT NCT01829373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lung Cancer Immunotherapy With Vaccine 1650-G and Yeast Derived β-Glucan
Lead sponsor
Edward Hirschowitz
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2011
Completion date
February 28, 2013
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer